Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunological and Clinical Effectiveness and Tolerability of Tetravalent Inactivated Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza
NCT06286488Phase 4Active, not recruiting
- Sponsor
- Medical University of Warsaw
- Start
- Sep 2020
- Primary completion
- Aug 2023
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine in influenza, sponsored by Medical University of Warsaw. Started Sep 2020; status: active, not recruiting.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT06286488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06286488.